Aursnes I, Litleskare I, Frøyland H, Abdelnoor M
Department of Pharmacotherapeutics, University of Oslo, Norway.
Blood Press. 1995 May;4(3):157-63. doi: 10.3109/08037059509077588.
We examined the relation between various drugs used for treating high blood pressure and the incidence of acute myocardial infarction with a case-control design. Four hospitals taking care of all patients in Oslo with acute myocardial infarction participated with a total of 95 hypertensive men and women under 75 years of age who had had an acute myocardial infarction. A total of 329 age and sex matched controls were hypertensive citizens in Oslo without myocardial infarction. Frequency of treatment with drugs and odds ratio of risks with these drugs were calculated. The risk (odds ratio) of myocardial infarction for drug treatment during the last five years versus non drug treatment was 0.70 (95% confidence interval 0.42-1.18). The risk for diuretics and beta-blockers tested against no treatment was 0.91 (0.52-1.61). The corresponding risk for vasodilating drugs was 0.43 (0.20-0.91). Four weeks of exposure to alpha-blockers, on the other hand, tested against other drug treatments, indicated an odds ratio of 4.62 (1.01-24.0) for individuals with a history of angina. These data confirm that treatment with diuretics and beta-blockers has only little effect on the incidence of myocardial infarction. As a whole, vasodilators are associated with a significant reduction in this incidence, but alpha-blockers enhance the risk in patients with angina.
我们采用病例对照设计研究了用于治疗高血压的各类药物与急性心肌梗死发病率之间的关系。奥斯陆负责诊治所有急性心肌梗死患者的四家医院参与了研究,共有95名年龄在75岁以下的高血压男性和女性发生了急性心肌梗死。共有329名年龄和性别匹配的对照者,他们是奥斯陆无心肌梗死的高血压市民。计算了药物治疗的频率以及使用这些药物的风险比值比。过去五年接受药物治疗与未接受药物治疗相比,心肌梗死的风险(比值比)为0.70(95%置信区间0.42 - 1.18)。与未治疗相比,利尿剂和β受体阻滞剂的风险为0.91(0.52 - 1.61)。血管扩张剂的相应风险为0.43(0.20 - 0.91)。另一方面,与其他药物治疗相比,有4周α受体阻滞剂暴露史的患者,有心绞痛病史者的比值比为4.62(1.01 - 24.0)。这些数据证实,利尿剂和β受体阻滞剂治疗对心肌梗死发病率影响甚微。总体而言,血管扩张剂与该发病率的显著降低相关,但α受体阻滞剂会增加心绞痛患者的风险。